肝、脾及咽部血管瘤的介入治疗

The Interventional Treatment of Hepatic, Splennic, and Pharyngeal Hemangiomas

本文同时应用鱼肝油酸钠,碘油及明胶海绵三种栓塞剂栓塞动脉治疗肝脏,咽部及脾脏血管瘤共35例,疗效显著,瘤体缩小达20％～90％,随访3～36个月无一例继续增大,同时还探讨了根据瘤体的大小,所用栓塞剂的适宜剂量,注射速度,以及疗效的观察方法和栓塞时应注意的问题,并说明了此种方法优于单一栓塞剂或或两种栓塞剂的合用。本文病例仅出现轻微的合并症。我们认为三种栓塞剂同时应用栓塞动脉治疗不同脏器和组织血管瘤是安全有效的。

Purpose: Three kinds of embolizing agents, sodium mirrhuate, lipiodol and gelfoam were used together in treating hemangiomas of liver, pharynx, and spleen by embolizing the arteries. Materials and methods: 35 patients with hemangiomas, 30 cases in liver, 1 in spleen, and 4 in pharynx, were treated with embolizing hepatic artery, splenic artery, maxillary arterry, and face artery, respectively. Results: Tumors decreased 20%～90% in size, and none of then had continued to grow after the treatment for 3～36 months. At the same time, the suitable dose of embolizing agent according to the size of the tumor, the injection speed, the observation of the curative effect and the precaution of the embolization were also discussed, It showed that the effect of this method was better than using only one or two kinds of embolizing agents togethes resued in only slight complications. Conclusion: We think this method is safe and effective by combined with embolizing agents in treating hemaiomas of different organs and tissues.